Advanced search
Publication Cover
Journal of Medical Economics Volume 17, 2014 - Issue 7
Submit an article Journal homepage
1,614
Views
9
CrossRef citations to date
0
Altmetric
Diabetes: Original article

Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective

Daniel ViriatoNovartis Farma SA Porto SalvoPortugalCorrespondence[email protected]
,
Frederico CaladoNovartis Pharma AG BaselSwitzerland
,
Jean-Bernard GruenbergerNovartis Pharma AG BaselSwitzerland
,
Siew Hwa OngNovartis Pharma AG BaselSwitzerland
,
Davide CarvalhoSão João Hospital, Faculty of Medicine, University of PortoPortugal
,
José Silva-NunesCurry Cabral Hospital LisbonPortugal
,
Sukhvinder JohalHERON Commercialization – A PAREXEL Company LondonUK
&
Ricardo VianaNovartis Farma SA Porto SalvoPortugal
 show all
Pages 499-507 | Accepted 04 Apr 2014, Published online: 23 Apr 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zhen Ruan, Huimin Zou, Qing Lei, Carolina Oi Lam Ung, Honghao Shi & Hao Hu. (2022) Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 555-574.
Read now
Gustavo Laine Araujo De Oliveira, Augusto Afonso Guerra Júnior, Brian Godman & Francisco de Assis Acurcio. (2017) Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications. Expert Review of Pharmacoeconomics & Outcomes Research 17:2, pages 109-119.
Read now
Ye-Fong Du, Horng-Yih Ou, Elizabeth A Beverly & Ching-Ju Chiu. (2014) Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options. Clinical Interventions in Aging 9, pages 1963-1980.
Read now

Articles from other publishers (6)

Jiejin Zhu, Ying Zhou, Qingyu Li & Gang Wang. (2023) Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review. Advances in Therapy.
Crossref
Chia-Chia Chen, Jin-Hua Chen, Chien-Lung Chen, Tzu-Jung Lai & Yu Ko. (2021) Health Utilities in Patients with Type 2 Diabetes in Taiwan. Healthcare 9:12, pages 1672.
Crossref
Dongzhe Hong, Lei Si, Minghuan Jiang, Hui Shao, Wai-kit Ming, Yingnan Zhao, Yan Li & Lizheng Shi. (2019) Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review. PharmacoEconomics.
Crossref
Néboa Zozaya, Margarita Capel, Susana Simón & Alfonso Soto-González. (2019) A systematic review of economic evaluations in non-insulin antidiabetic treatments for patients with type 2 diabetes mellitus. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2019, pages 228424031987657.
Crossref
Hara Kousoulakou, Magdalini Hatzikou, Varvara Baroutsou & John Yfantopoulos. (2017) Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece. Cost Effectiveness and Resource Allocation 15:1.
Crossref
Alexandre Baptista, Inês Teixeira, Sónia Romano, António Vaz Carneiro & Julian Perelman. (2016) The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies. The European Journal of Health Economics 18:8, pages 937-965.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.